Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiomyopathy, Hypertrophic | 97 | 2024 | 1265 | 17.630 |
Why?
|
Sarcomeres | 40 | 2024 | 374 | 8.610 |
Why?
|
Genetic Testing | 30 | 2024 | 3444 | 2.950 |
Why?
|
Hypertrophy, Left Ventricular | 23 | 2023 | 859 | 2.790 |
Why?
|
Benzylamines | 6 | 2021 | 223 | 2.100 |
Why?
|
Uracil | 6 | 2021 | 165 | 1.940 |
Why?
|
Cardiac Myosins | 14 | 2023 | 117 | 1.690 |
Why?
|
Mutation | 43 | 2024 | 29786 | 1.400 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 6 | 2023 | 451 | 1.380 |
Why?
|
Ventricular Function, Left | 16 | 2023 | 3670 | 1.200 |
Why?
|
Myosin Heavy Chains | 13 | 2021 | 414 | 1.190 |
Why?
|
Magnetic Resonance Imaging, Cine | 12 | 2022 | 964 | 1.180 |
Why?
|
Cardiomyopathy, Dilated | 7 | 2017 | 851 | 1.160 |
Why?
|
Defibrillators, Implantable | 7 | 2021 | 1440 | 1.090 |
Why?
|
Ventricular Dysfunction, Left | 10 | 2023 | 2073 | 1.080 |
Why?
|
Cardiomyopathy, Hypertrophic, Familial | 5 | 2012 | 66 | 1.010 |
Why?
|
Heart Failure | 18 | 2023 | 10900 | 1.000 |
Why?
|
Genetic Counseling | 6 | 2024 | 600 | 0.980 |
Why?
|
Myocardium | 13 | 2023 | 4776 | 0.910 |
Why?
|
Death, Sudden, Cardiac | 15 | 2022 | 1541 | 0.890 |
Why?
|
Ventricular Remodeling | 9 | 2023 | 1224 | 0.860 |
Why?
|
Troponin T | 9 | 2023 | 754 | 0.850 |
Why?
|
Genetic Predisposition to Disease | 31 | 2023 | 17446 | 0.850 |
Why?
|
Myocardial Contraction | 7 | 2020 | 1585 | 0.850 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 2022 | 76 | 0.840 |
Why?
|
Cardiomyopathies | 10 | 2023 | 1912 | 0.830 |
Why?
|
Echocardiography | 21 | 2021 | 5102 | 0.830 |
Why?
|
Pedigree | 15 | 2023 | 4644 | 0.830 |
Why?
|
Carrier Proteins | 18 | 2022 | 5021 | 0.810 |
Why?
|
Heart Ventricles | 11 | 2021 | 3821 | 0.720 |
Why?
|
Heterozygote | 6 | 2021 | 2804 | 0.680 |
Why?
|
Phenotype | 32 | 2023 | 16365 | 0.670 |
Why?
|
Heart | 6 | 2024 | 4467 | 0.620 |
Why?
|
Echocardiography, Doppler | 8 | 2016 | 935 | 0.620 |
Why?
|
Atrial Fibrillation | 7 | 2022 | 5034 | 0.570 |
Why?
|
Registries | 14 | 2023 | 8089 | 0.560 |
Why?
|
Losartan | 4 | 2023 | 299 | 0.530 |
Why?
|
Founder Effect | 2 | 2020 | 189 | 0.490 |
Why?
|
Genotype | 17 | 2020 | 12951 | 0.490 |
Why?
|
Cardiovascular Agents | 2 | 2020 | 850 | 0.490 |
Why?
|
Diltiazem | 1 | 2014 | 133 | 0.480 |
Why?
|
Calcium Channel Blockers | 3 | 2020 | 690 | 0.480 |
Why?
|
Diastole | 8 | 2018 | 791 | 0.470 |
Why?
|
Humans | 135 | 2024 | 744343 | 0.460 |
Why?
|
Genetic Variation | 10 | 2021 | 6544 | 0.460 |
Why?
|
Double-Blind Method | 11 | 2021 | 12026 | 0.460 |
Why?
|
Genetics, Medical | 3 | 2018 | 338 | 0.430 |
Why?
|
Adult | 63 | 2023 | 214055 | 0.430 |
Why?
|
Fibrosis | 8 | 2022 | 2029 | 0.430 |
Why?
|
Heart-Assist Devices | 3 | 2021 | 1194 | 0.420 |
Why?
|
Mitral Valve | 3 | 2018 | 1491 | 0.390 |
Why?
|
Contrast Media | 4 | 2022 | 5300 | 0.390 |
Why?
|
Young Adult | 30 | 2021 | 56430 | 0.390 |
Why?
|
Exercise Tolerance | 5 | 2021 | 770 | 0.390 |
Why?
|
Male | 80 | 2023 | 350118 | 0.380 |
Why?
|
Heart Valve Diseases | 1 | 2018 | 1073 | 0.370 |
Why?
|
Procollagen | 1 | 2010 | 185 | 0.360 |
Why?
|
Female | 80 | 2023 | 380194 | 0.350 |
Why?
|
Adolescent | 34 | 2023 | 85781 | 0.350 |
Why?
|
Middle Aged | 60 | 2022 | 213383 | 0.350 |
Why?
|
Muscle Proteins | 5 | 2021 | 1159 | 0.340 |
Why?
|
Cardiology | 2 | 2018 | 1668 | 0.340 |
Why?
|
Cost of Illness | 1 | 2018 | 1859 | 0.330 |
Why?
|
Glycogen Storage Disease Type IIb | 2 | 2023 | 18 | 0.320 |
Why?
|
Child | 24 | 2023 | 77709 | 0.320 |
Why?
|
Disease Progression | 12 | 2020 | 13284 | 0.310 |
Why?
|
Heart Diseases | 2 | 2013 | 2788 | 0.290 |
Why?
|
Penetrance | 3 | 2023 | 381 | 0.290 |
Why?
|
Electrocardiography | 7 | 2018 | 6442 | 0.290 |
Why?
|
Mutation, Missense | 6 | 2021 | 2564 | 0.280 |
Why?
|
Predictive Value of Tests | 13 | 2022 | 15076 | 0.280 |
Why?
|
Lamin Type A | 2 | 2017 | 190 | 0.280 |
Why?
|
Risk Factors | 16 | 2023 | 72290 | 0.270 |
Why?
|
Genetics | 2 | 2024 | 112 | 0.260 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2006 | 322 | 0.260 |
Why?
|
Extracellular Matrix | 1 | 2013 | 1741 | 0.260 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2006 | 153 | 0.250 |
Why?
|
Patient Care | 1 | 2010 | 640 | 0.250 |
Why?
|
DNA Mutational Analysis | 6 | 2017 | 4186 | 0.250 |
Why?
|
Primary Prevention | 2 | 2021 | 1167 | 0.240 |
Why?
|
Prognosis | 12 | 2023 | 29063 | 0.240 |
Why?
|
Arrhythmias, Cardiac | 4 | 2023 | 2268 | 0.230 |
Why?
|
Disease | 1 | 2009 | 680 | 0.230 |
Why?
|
Stroke Volume | 6 | 2023 | 5007 | 0.220 |
Why?
|
Child, Preschool | 13 | 2022 | 41006 | 0.220 |
Why?
|
Aged | 37 | 2022 | 163280 | 0.220 |
Why?
|
Cardiovascular Diseases | 5 | 2020 | 15165 | 0.210 |
Why?
|
Sex Characteristics | 4 | 2022 | 2585 | 0.210 |
Why?
|
Hypertrophy | 2 | 2022 | 569 | 0.210 |
Why?
|
Cardiomyopathy, Restrictive | 1 | 2022 | 60 | 0.210 |
Why?
|
Risk Assessment | 10 | 2022 | 23338 | 0.200 |
Why?
|
Tropomyosin | 3 | 2013 | 102 | 0.200 |
Why?
|
Databases, Genetic | 2 | 2021 | 1783 | 0.200 |
Why?
|
Asymptomatic Diseases | 3 | 2020 | 551 | 0.200 |
Why?
|
Heart Arrest | 2 | 2023 | 1470 | 0.200 |
Why?
|
Genomics | 4 | 2024 | 5720 | 0.190 |
Why?
|
Recovery of Function | 3 | 2020 | 2925 | 0.190 |
Why?
|
Family | 4 | 2024 | 3147 | 0.190 |
Why?
|
Point Mutation | 2 | 2010 | 1623 | 0.190 |
Why?
|
Genome, Human | 3 | 2021 | 4420 | 0.180 |
Why?
|
Denmark | 2 | 2019 | 738 | 0.180 |
Why?
|
Genes, Dominant | 3 | 2013 | 880 | 0.180 |
Why?
|
Ventricular Outflow Obstruction | 2 | 2020 | 272 | 0.180 |
Why?
|
Early Diagnosis | 2 | 2018 | 1184 | 0.170 |
Why?
|
Lysosomal-Associated Membrane Protein 2 | 4 | 2023 | 52 | 0.170 |
Why?
|
Twins, Monozygotic | 1 | 2021 | 458 | 0.170 |
Why?
|
Genetic Markers | 4 | 2015 | 2634 | 0.170 |
Why?
|
Cardiac Imaging Techniques | 2 | 2018 | 269 | 0.160 |
Why?
|
Heart Septum | 1 | 2020 | 313 | 0.160 |
Why?
|
Muscle Relaxation | 2 | 2020 | 142 | 0.160 |
Why?
|
Systole | 3 | 2018 | 958 | 0.160 |
Why?
|
Online Systems | 1 | 2019 | 184 | 0.160 |
Why?
|
Mortality | 2 | 2020 | 2864 | 0.160 |
Why?
|
Heart Atria | 3 | 2021 | 1357 | 0.160 |
Why?
|
Mass Screening | 4 | 2019 | 5255 | 0.160 |
Why?
|
Papillary Muscles | 1 | 2018 | 203 | 0.160 |
Why?
|
Troponin I | 2 | 2014 | 619 | 0.150 |
Why?
|
Age Factors | 5 | 2020 | 18370 | 0.150 |
Why?
|
Peptide Fragments | 1 | 2010 | 5097 | 0.150 |
Why?
|
Myofibrils | 2 | 2020 | 146 | 0.150 |
Why?
|
Allelic Imbalance | 1 | 2017 | 77 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 7 | 2021 | 35421 | 0.150 |
Why?
|
Hospitals, Special | 1 | 2017 | 101 | 0.150 |
Why?
|
Myocytes, Cardiac | 3 | 2020 | 1637 | 0.140 |
Why?
|
Atrial Function, Left | 1 | 2017 | 173 | 0.140 |
Why?
|
Cardiovascular System | 1 | 2024 | 832 | 0.140 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2020 | 841 | 0.140 |
Why?
|
MAP Kinase Kinase Kinases | 2 | 2014 | 261 | 0.140 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 1996 | 230 | 0.140 |
Why?
|
Blood Platelet Disorders | 1 | 1996 | 58 | 0.130 |
Why?
|
Homozygote | 1 | 2000 | 1785 | 0.130 |
Why?
|
Patient Selection | 2 | 2018 | 4215 | 0.130 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 3 | 2022 | 314 | 0.130 |
Why?
|
Brazil | 1 | 2019 | 1270 | 0.130 |
Why?
|
Retrospective Studies | 11 | 2022 | 77449 | 0.130 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1677 | 0.130 |
Why?
|
Cardiac Volume | 1 | 2015 | 210 | 0.130 |
Why?
|
Cross-Sectional Studies | 6 | 2023 | 25043 | 0.120 |
Why?
|
Time Factors | 7 | 2019 | 40075 | 0.120 |
Why?
|
Canada | 1 | 2019 | 2065 | 0.120 |
Why?
|
Arterio-Arterial Fistula | 1 | 2013 | 19 | 0.120 |
Why?
|
Communication | 2 | 2018 | 3749 | 0.120 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1405 | 0.120 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 1996 | 241 | 0.120 |
Why?
|
Professional-Family Relations | 1 | 2017 | 482 | 0.110 |
Why?
|
Cohort Studies | 8 | 2023 | 40561 | 0.110 |
Why?
|
Collagen | 2 | 2013 | 2689 | 0.110 |
Why?
|
Polymorphism, Genetic | 2 | 2020 | 4328 | 0.110 |
Why?
|
Leukemia, Myeloid | 1 | 1996 | 707 | 0.110 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2017 | 1213 | 0.110 |
Why?
|
Health Education | 1 | 2019 | 1056 | 0.110 |
Why?
|
Exercise Test | 2 | 2017 | 2074 | 0.110 |
Why?
|
Alleles | 2 | 2017 | 6933 | 0.100 |
Why?
|
Lod Score | 2 | 2006 | 614 | 0.100 |
Why?
|
Hemodynamics | 3 | 2020 | 4199 | 0.100 |
Why?
|
Catheter Ablation | 2 | 2021 | 2758 | 0.100 |
Why?
|
Sequence Analysis, DNA | 3 | 2014 | 4803 | 0.100 |
Why?
|
Heart Function Tests | 2 | 2014 | 330 | 0.090 |
Why?
|
Incidence | 5 | 2022 | 20947 | 0.090 |
Why?
|
Pilot Projects | 4 | 2019 | 8324 | 0.090 |
Why?
|
Patient Participation | 1 | 2019 | 1457 | 0.090 |
Why?
|
alpha-Galactosidase | 1 | 2010 | 57 | 0.090 |
Why?
|
Case-Control Studies | 6 | 2021 | 21746 | 0.090 |
Why?
|
Gadolinium DTPA | 1 | 2013 | 836 | 0.090 |
Why?
|
Ventricular Myosins | 1 | 2009 | 50 | 0.090 |
Why?
|
Endothelial Cells | 1 | 2022 | 3479 | 0.090 |
Why?
|
Fabry Disease | 1 | 2010 | 90 | 0.080 |
Why?
|
Muscle Cells | 1 | 2010 | 197 | 0.080 |
Why?
|
Information Dissemination | 1 | 2017 | 1099 | 0.080 |
Why?
|
Follow-Up Studies | 9 | 2021 | 39050 | 0.080 |
Why?
|
Treatment Outcome | 6 | 2020 | 63114 | 0.080 |
Why?
|
Survival Rate | 2 | 2020 | 12788 | 0.080 |
Why?
|
Amino Acid Substitution | 2 | 2006 | 1791 | 0.080 |
Why?
|
Logistic Models | 3 | 2014 | 13408 | 0.080 |
Why?
|
Therapeutics | 1 | 2009 | 116 | 0.080 |
Why?
|
Animals | 9 | 2022 | 168757 | 0.080 |
Why?
|
Myosins | 1 | 2010 | 409 | 0.080 |
Why?
|
Family Health | 1 | 2013 | 1282 | 0.080 |
Why?
|
Policy Making | 1 | 2012 | 554 | 0.080 |
Why?
|
Primary Health Care | 2 | 2015 | 4558 | 0.080 |
Why?
|
Medical History Taking | 1 | 2012 | 783 | 0.080 |
Why?
|
Cause of Death | 1 | 2018 | 3584 | 0.080 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2020 | 1240 | 0.080 |
Why?
|
Health Status | 1 | 2021 | 4034 | 0.080 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3647 | 0.080 |
Why?
|
American Heart Association | 1 | 2012 | 1056 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 9959 | 0.070 |
Why?
|
Collagen Type I | 1 | 2010 | 592 | 0.070 |
Why?
|
Patient Care Team | 1 | 2018 | 2531 | 0.070 |
Why?
|
United States | 9 | 2022 | 69872 | 0.070 |
Why?
|
Actins | 1 | 2014 | 2121 | 0.070 |
Why?
|
MicroRNAs | 1 | 2023 | 3752 | 0.070 |
Why?
|
Blood Volume | 1 | 2008 | 565 | 0.070 |
Why?
|
Research | 1 | 2015 | 1999 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12354 | 0.070 |
Why?
|
Infant | 5 | 2022 | 35136 | 0.070 |
Why?
|
Troponin | 1 | 2010 | 524 | 0.070 |
Why?
|
Societies, Medical | 1 | 2018 | 3743 | 0.070 |
Why?
|
Models, Molecular | 1 | 2016 | 5456 | 0.070 |
Why?
|
Disease Models, Animal | 2 | 2022 | 18029 | 0.070 |
Why?
|
Haplotypes | 2 | 2006 | 2779 | 0.070 |
Why?
|
Tandem Repeat Sequences | 1 | 2006 | 185 | 0.060 |
Why?
|
Models, Statistical | 1 | 2020 | 5102 | 0.060 |
Why?
|
Contractile Proteins | 1 | 2006 | 246 | 0.060 |
Why?
|
Protein Kinases | 1 | 2012 | 1640 | 0.060 |
Why?
|
Codon | 1 | 2006 | 611 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3158 | 0.060 |
Why?
|
Prevalence | 2 | 2018 | 15226 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2013 | 6365 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7279 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 8949 | 0.060 |
Why?
|
Anxiety Disorders | 1 | 2015 | 2690 | 0.060 |
Why?
|
Transforming Growth Factors | 1 | 2023 | 76 | 0.060 |
Why?
|
Databases, Factual | 1 | 2018 | 7729 | 0.060 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2006 | 611 | 0.050 |
Why?
|
Multienzyme Complexes | 1 | 2006 | 686 | 0.050 |
Why?
|
Genetic Heterogeneity | 1 | 2006 | 733 | 0.050 |
Why?
|
Computational Biology | 1 | 2015 | 3521 | 0.050 |
Why?
|
Heart Transplantation | 4 | 2020 | 3110 | 0.050 |
Why?
|
Coronary Circulation | 1 | 2008 | 1572 | 0.050 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2005 | 488 | 0.050 |
Why?
|
Aneurysm, False | 1 | 2005 | 276 | 0.050 |
Why?
|
Motion | 1 | 2006 | 798 | 0.050 |
Why?
|
Energy Metabolism | 2 | 2020 | 2899 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 7023 | 0.050 |
Why?
|
Long QT Syndrome | 1 | 2006 | 453 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2018 | 3327 | 0.050 |
Why?
|
Ion Channels | 1 | 2006 | 1056 | 0.050 |
Why?
|
Prospective Studies | 7 | 2023 | 53288 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 15519 | 0.050 |
Why?
|
Heart Rate | 1 | 2012 | 4091 | 0.050 |
Why?
|
Mice | 4 | 2022 | 81183 | 0.050 |
Why?
|
Calcium | 2 | 2013 | 5756 | 0.050 |
Why?
|
Iceland | 1 | 2020 | 183 | 0.040 |
Why?
|
Heredity | 1 | 2020 | 154 | 0.040 |
Why?
|
Biomedical Research | 1 | 2015 | 3309 | 0.040 |
Why?
|
Age of Onset | 2 | 2020 | 3271 | 0.040 |
Why?
|
DNA | 2 | 2010 | 7301 | 0.040 |
Why?
|
Algorithms | 4 | 2020 | 13881 | 0.040 |
Why?
|
Peptides | 1 | 2010 | 4409 | 0.040 |
Why?
|
Research Design | 1 | 2014 | 5987 | 0.040 |
Why?
|
Gadolinium | 1 | 2022 | 952 | 0.040 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2023 | 924 | 0.040 |
Why?
|
Chromosome Mapping | 1 | 2006 | 4740 | 0.040 |
Why?
|
Base Sequence | 1 | 2009 | 12797 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2023 | 711 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 12745 | 0.040 |
Why?
|
Endocardium | 1 | 2018 | 263 | 0.040 |
Why?
|
Victoria | 1 | 2016 | 67 | 0.040 |
Why?
|
Molecular Dynamics Simulation | 1 | 2020 | 413 | 0.040 |
Why?
|
Capillaries | 1 | 2020 | 773 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2015 | 14722 | 0.040 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2017 | 234 | 0.040 |
Why?
|
Electric Countershock | 1 | 2020 | 534 | 0.040 |
Why?
|
Curriculum | 2 | 2024 | 3605 | 0.040 |
Why?
|
Virulence | 1 | 2020 | 1333 | 0.040 |
Why?
|
Health Communication | 1 | 2019 | 214 | 0.030 |
Why?
|
Gene Duplication | 1 | 2017 | 329 | 0.030 |
Why?
|
Area Under Curve | 1 | 2020 | 1654 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2020 | 19905 | 0.030 |
Why?
|
Adenosine Triphosphatases | 1 | 2020 | 839 | 0.030 |
Why?
|
France | 1 | 2016 | 517 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 2007 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 3507 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15540 | 0.030 |
Why?
|
Internationality | 1 | 2020 | 1003 | 0.030 |
Why?
|
Singapore | 1 | 2015 | 295 | 0.030 |
Why?
|
London | 1 | 2014 | 233 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 2959 | 0.030 |
Why?
|
Tachycardia, Ventricular | 1 | 2002 | 1273 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2020 | 1869 | 0.030 |
Why?
|
Pericardium | 1 | 2018 | 667 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2013 | 6487 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2014 | 3508 | 0.030 |
Why?
|
Incidental Findings | 1 | 2018 | 689 | 0.030 |
Why?
|
Cardiomegaly | 1 | 2016 | 620 | 0.030 |
Why?
|
Isometric Contraction | 1 | 2013 | 143 | 0.030 |
Why?
|
Italy | 1 | 2014 | 832 | 0.030 |
Why?
|
Genome-Wide Association Study | 2 | 2023 | 12261 | 0.030 |
Why?
|
Phobic Disorders | 1 | 2015 | 439 | 0.030 |
Why?
|
Anti-Anxiety Agents | 1 | 2015 | 390 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2020 | 57776 | 0.030 |
Why?
|
Myocardial Infarction | 2 | 2005 | 11727 | 0.030 |
Why?
|
Ventricular Fibrillation | 1 | 2014 | 538 | 0.030 |
Why?
|
Netherlands | 1 | 2016 | 2170 | 0.030 |
Why?
|
Protein Conformation | 1 | 2020 | 4011 | 0.030 |
Why?
|
Panic Disorder | 1 | 2015 | 616 | 0.030 |
Why?
|
Genetic Diseases, Inborn | 1 | 2016 | 587 | 0.020 |
Why?
|
Inservice Training | 1 | 2014 | 392 | 0.020 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2013 | 491 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3129 | 0.020 |
Why?
|
Oncogenes | 1 | 1996 | 1265 | 0.020 |
Why?
|
Blood Pressure | 2 | 2021 | 8554 | 0.020 |
Why?
|
Morbidity | 1 | 2015 | 1769 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 1996 | 1782 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2015 | 1681 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2020 | 1736 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2014 | 840 | 0.020 |
Why?
|
Quality of Life | 2 | 2021 | 12804 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2023 | 12959 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2012 | 675 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2014 | 2025 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2012 | 1526 | 0.020 |
Why?
|
Health Promotion | 1 | 2019 | 2205 | 0.020 |
Why?
|
Stroke | 2 | 2020 | 9981 | 0.020 |
Why?
|
Disease Management | 1 | 2017 | 2459 | 0.020 |
Why?
|
Exercise | 1 | 2023 | 5615 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2013 | 1442 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10397 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3920 | 0.020 |
Why?
|
Psychotherapy | 1 | 2015 | 1643 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3022 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9687 | 0.020 |
Why?
|
Acute Disease | 1 | 1996 | 7149 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 4933 | 0.020 |
Why?
|
Autopsy | 1 | 2009 | 1020 | 0.020 |
Why?
|
Atherectomy | 1 | 2005 | 47 | 0.020 |
Why?
|
History, 20th Century | 1 | 2013 | 2740 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2008 | 1590 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2020 | 4371 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2020 | 19229 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3610 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2015 | 20129 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5137 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3597 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 12720 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9849 | 0.010 |
Why?
|
Phosphorylation | 1 | 2013 | 8436 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 2015 | 2861 | 0.010 |
Why?
|
Pregnancy | 2 | 2015 | 29144 | 0.010 |
Why?
|
Medical Records | 1 | 2005 | 1413 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2014 | 3843 | 0.010 |
Why?
|
Equipment Design | 1 | 2008 | 3582 | 0.010 |
Why?
|
Point-of-Care Systems | 1 | 2008 | 1177 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2014 | 3923 | 0.010 |
Why?
|
Treatment Failure | 1 | 2005 | 2618 | 0.010 |
Why?
|
Clinical Competence | 1 | 2014 | 4687 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2008 | 5078 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2015 | 4266 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 12072 | 0.010 |
Why?
|
Stents | 1 | 2005 | 3280 | 0.010 |
Why?
|
Coronary Disease | 1 | 2005 | 6077 | 0.010 |
Why?
|
Internship and Residency | 1 | 2008 | 5788 | 0.000 |
Why?
|